Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study
Pediatric Rheumatology（2015）
关键词
Withdrawal Period,Canakinumab,Periodic Fever Syndrome,Global Assessment Score,HIDS Patient
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要